A fascinating glimpse inside the life-and-death business of
biotechnology.
"A tour-de-force for anyone who is interested in the biotech
industry. I applaud the enormous achievement of Cynthia
Robbins-Roth." -Frederick Frank, Senior Managing Director
Vice Chair, Lehman Brothers
"From Alchemy to IPO tells the dramatic story of this
revolutionary industry as only an insider can." -George Rathmann,
President and CEO, ICOS Corporation, Chairman Emeritus, Amgen
Written by a well-known industry insider, From Alchemy to IPO
addresses the coming-of-age of biotech products and companies and
traces the history of biotechnology from its early inception in the
seventies to today''s heyday of new solutions and breakthrough
treatments. It describes the amazing entrepreneurial trail of
product development, novel business models, and critical trials
that eventually pave the way to market. This is the first book to
accurately record the inner workings of an
industry-biotechnology-that''s on the verge of living up to its
monumental promise to change the world as we know it.
關於作者：
Cynthia Robbins-Roth, Ph.D., is the founder of BioVenture
Consultants, which provides strategic planning and financial
assessment to biotech start-ups, pharmaceutical companies, and
venture-capital firms. Her biotech column appears regularly in
Forbes magazine, and Forbes ASAP recently named her one of the top
twenty-five biotech all-stars of 1999. She lives in San Mateo,
California.
目錄：
PART ONE:THE ROOTS OF
BIOTECHNOLOGY
1 Biotech in the Beginning
2 Genentech: The Leader of the Pack
3 The Amgen Story
4 An Exception to Every Rule: Genzyme
5 The Other Biotech: Monoclonal Antibodies
PART TWO:BIOTECH''S BUILDING BLOCKS
6 Biotech Star Wars
7 The Human Genome Project
8 Tools for Genome Studies: BioChips and Microarrays
9 Treating Disease at the Gene: Antisense Drugs
10 Gene Therapy
……
購物車/收銀台(0) | 在線留言板
| 付款方式
| 運費計算
| 聯絡我們
| 幫助中心 |
加入書簽
HOME
新書上架
